Myomo (MYO) Net Cash Flow Growth (5y) (2021 - 2025)
Powered by 
Analysis
Myomo (MYO) Net Cash Flow Growth (5y) (2021 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -21.60% |
| Jun 30, 2025 | -13.44% |
| Mar 31, 2025 | -20.09% |
| Dec 31, 2024 | 164.60% |
| Sep 30, 2024 | 19.95% |
| Jun 30, 2024 | 16.67% |
| Mar 31, 2024 | -20.40% |
| Dec 31, 2023 | 52.57% |
| Sep 30, 2023 | 18.68% |
| Jun 30, 2023 | -6.21% |
| Mar 31, 2023 | 27.58% |
| Dec 31, 2022 | -17.73% |
| Sep 30, 2022 | -5.44% |
| Jun 30, 2022 | -19.85% |
| Mar 31, 2022 | -44.22% |
| Dec 31, 2021 | 57.11% |
| Sep 30, 2021 | -50.51% |